ICCC - Immucell Corp.
IEX Last Trade
3.74
-0.070 -1.872%
Share volume: 39,701
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.81
-0.07
-1.84%
Summary score
5%
Profitability
0%
Dept financing
11%
Liquidity
38%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-2.15%
Return on assets
-1.37%
Return on sales
-15.57%
Return on invested capital
-2.12%
Total debt ratio
32.57%
Debt ratio change over timeo
3.08%
Current Ratio
5.19%
Quick Ratio
3.69%
Cash Position Ratio
2.78%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.77%
Return on assets
-2.15%
Return on sales
-20.67%
Return on invested capital
-3.41%
Total debt ratio
41.57%
Debt ratio change over timeo
-15.66%
Current Ratio
2.91%
Quick Ratio
1.02%
Cash Position Ratio
0.35%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-1.78%
Return on assets
-0.7%
Return on sales
-4.13%
Return on invested capital
-1.59%
Total debt ratio
42.77%
Debt ratio change over time
-11.56%
Current Ratio
2.71%
Quick Ratio
1%
Cash Position Ratio
0.23%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-18.33%
Return on assets
-23.5%
Return on sales
674.7%
Return on invested capital
-12.95%
Total debt ratio
308.11%
Debt ratio change over time
3.08%
Current Ratio
217.85%
Quick Ratio
195.81%
Cash Position Ratio
155.98%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ICCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -2.15% | 13.79% | 34.47% | 7.43% |
| Return on assets | -1.37% | 2.76% | 3.15% | 5.62% |
| Return on sales | -15.57% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -2.12% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 32.57% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 3.08% | 308.97% | -6.99% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.91% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.02% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.35% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 12% | 28% | 65% |
| Short-term ratios | ICCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.77% | 13.77% | 13.25% | 3.8% |
| Return on assets | -2.15% | 2.43% | 1.89% | 3.09% |
| Return on sales | -20.67% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -3.41% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 41.57% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -15.66% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 2.91% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.02% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.35% | 0.36% | 1.28% | 2.93% |
| Liquididy | 22% | 12% | 31% | 75% |